Abstract
Correction for 'Efficacy of proprietary Lactobacillus casei for anti-tuberculosis associated gastrointestinal adverse reactions in adult patients: a randomized, open-label, dose-response trial' by Song Lin et al., Food Funct., 2020, 11, 370-377.
Highlights
Correction for ‘Efficacy of proprietary Lactobacillus casei for anti-tuberculosis associated gastrointestinal adverse reactions in adult patients: a randomized, open-label, dose–response trial’ by Song Lin et al, Food Funct., 2020, 11, 370–377
The authors regret that the L. casei preparation used was not produced by Yakult Honsha Co., Ltd (Tokyo, Japan) as indicated in the original manuscript
The L. casei preparation, which was a commercial probiotic fermented milk drink manufactured by Yakult (China) Corporation, does not contain fructose
Summary
Correction for ‘Efficacy of proprietary Lactobacillus casei for anti-tuberculosis associated gastrointestinal adverse reactions in adult patients: a randomized, open-label, dose–response trial’ by Song Lin et al, Food Funct., 2020, 11, 370–377. Correction: Efficacy of proprietary Lactobacillus casei for anti-tuberculosis associated Cite this: Food Funct., 2020, 11, 3751 gastrointestinal adverse reactions in adult patients: a randomized, open-label, dose–response trial Song Lin,a,b Shanliang Zhao,c Jiahong Liu,d Jianwen Zhang,a Chao Zhang,a Haibo Hao,a Yuxia Sun,a Jing Cai,a Yang Yang,a Yan Ma,a Yuanyuan Li,a Jinyu Wanga and Aiguo Ma*a
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have